Deutsche Bank AG Buys New Position in Aspen Aerogels, Inc. $ASPN

Key Points

• Deutsche Bank purchased 372,077 Aspen Aerogels shares worth approximately $2.36 million, representing about 0.45% of the company. Institutional investors collectively own 97.64% of ASPN.
• Aspen Aerogels reported quarterly revenue of $49.85 million, exceeding estimates of $42.42 million, while adjusted EPS of negative $0.22 slightly beat expectations. The company remains unprofitable, with a negative net margin of 62.45%.
• Analyst sentiment is mixed, resulting in an average rating of “Hold” and an average price target of $5.94, compared with the stock’s reported opening price of $5.22.

Deutsche Bank AG purchased a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 372,077 shares of the construction company's stock, valued at approximately $2,359,000. Deutsche Bank AG owned approximately 0.45% of Aspen Aerogels as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Rice Hall James & Associates LLC boosted its stake in shares of Aspen Aerogels by 9.2% in the first quarter. Rice Hall James & Associates LLC now owns 1,552,628 shares of the construction company's stock valued at $5,310,000 after purchasing an additional 131,023 shares during the period. Needham Investment Management LLC increased its stake in Aspen Aerogels by 26.5% during the 4th quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company's stock worth $12,315,000 after buying an additional 912,000 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in Aspen Aerogels during the 2nd quarter worth $682,000. Lazard Asset Management LLC acquired a new position in Aspen Aerogels in the 1st quarter worth $485,000. Finally, First Eagle Investment Management LLC lifted its holdings in Aspen Aerogels by 20.3% in the 4th quarter. First Eagle Investment Management LLC now owns 622,487 shares of the construction company's stock worth $1,762,000 after buying an additional 105,164 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Price Performance

Shares of NYSE ASPN opened at $5.22 on Friday. The company has a current ratio of 2.52, a quick ratio of 2.24 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $433.54 million, a price-to-earnings ratio of -3.41 and a beta of 2.99. Aspen Aerogels, Inc. has a twelve month low of $2.30 and a twelve month high of $9.35. The business has a 50 day simple moving average of $5.42 and a 200-day simple moving average of $4.64.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) EPS for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. The firm had revenue of $49.85 million during the quarter, compared to the consensus estimate of $42.42 million. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. Aspen Aerogels has set its Q3 2026 guidance at -0.110--0.070 EPS. As a group, equities research analysts expect that Aspen Aerogels, Inc. will post -0.69 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Barclays upped their price objective on shares of Aspen Aerogels from $4.00 to $5.00 and gave the company an "underweight" rating in a research report on Tuesday, August 11th. Roth Capital reiterated a "buy" rating and issued a $7.75 price target on shares of Aspen Aerogels in a research note on Friday, August 7th. Weiss Ratings reissued a "sell (d-)" rating on shares of Aspen Aerogels in a report on Wednesday, June 24th. B. Riley Financial restated a "buy" rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Finally, Wall Street Zen downgraded Aspen Aerogels from a "hold" rating to a "sell" rating in a report on Saturday, August 15th. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Aspen Aerogels currently has an average rating of "Hold" and an average target price of $5.94.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company's product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source